CD226 and neoplasm: DNAM-1 (DNAX Accessory Molecule-1), which is important in NK cell-mediated tumor immunity (45–48), is expressed on the surface of NK cells and is involved in NK cell activation by mediating adhesion to cells expressing its ligands (CD112 and CD155) (49, 50).